Stephen J. Schuster, MD, discusses the latest advances in clinical research for the treatment of the lymphomas as presented at the American Society of Hematology (ASH) meeting in 2013. Dr. Schuster is the Director of the Lymphoma program at Penn Medicine and the Abramson Cancer Center in Philadelphia.

Related Links

• MAGE-A3/6 and NY-ESO-1 immunotherapy administered post-ASCT in patients with advanced myeloma
• View Clinical Trial
• Dr Schuster’s Profile